Trial · NCT03211247
Results by group41
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 41
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Treatment Responders at Month 12 | Part B Viaskin Peanut 250 mcg | 67.0 | 95% Confidence Interval 60.93 to 73.01 | Percentage of participants | |
| Percentage of Treatment Responders at Month 12 | Part B Placebo | 33.5 | 95% Confidence Interval 24.84 to 42.24 | Percentage of participants | |
| Percentage of Treatment Responders at Month 12 | Part A Viaskin Peanut 250 mcg | 52.4 | 95% Confidence Interval 29.8 to 74.3 | Percentage of participants | |
| Percentage of Treatment Responders at Month 12 | Part A Viaskin Peanut 100 mcg | 70.0 | 95% Confidence Interval 45.7 to 88.1 | Percentage of participants | |
| Percentage of Treatment Responders at Month 12 | Part A Placebo | 60.0 | 95% Confidence Interval 26.2 to 74.3 | Percentage of participants | |
| Cumulative Reactive Dose (CRD) of Peanut Protein at Month 12 Using Analysis of Covariance (ANCOVA) Model | Part B Viaskin Peanut 250 mcg | 1010.31 | 95% Confidence Interval 842.18 to 1212.01 | milligram (mg) | |
| Cumulative Reactive Dose (CRD) of Peanut Protein at Month 12 Using Analysis of Covariance (ANCOVA) Model | Part B Placebo | 322.57 | 95% Confidence Interval 248.37 to 418.94 | milligram (mg) | |
| Cumulative Reactive Dose (CRD) of Peanut Protein at Month 12 Using Analysis of Covariance (ANCOVA) Model | Part A Viaskin Peanut 250 mcg | 788.74 | 95% Confidence Interval 220.20 to 2825.24 | milligram (mg) | |
| Cumulative Reactive Dose (CRD) of Peanut Protein at Month 12 Using Analysis of Covariance (ANCOVA) Model | Part A Viaskin Peanut 100 mcg | 1155.90 | 95% Confidence Interval 367.53 to 3635.38 | milligram (mg) | |
| Cumulative Reactive Dose (CRD) of Peanut Protein at Month 12 Using Analysis of Covariance (ANCOVA) Model | Part A Placebo | 1153.47 | 95% Confidence Interval 474.34 to 2804.91 | milligram (mg) | |
| Change From Baseline in CRD of Peanut Protein to Month 12 | Part B Viaskin Peanut 250 mcg | 1300.0 | Inter-Quartile Range 140.0 to 3000.0 | mg | |
| Change From Baseline in CRD of Peanut Protein to Month 12 | Part B Placebo | 0.0 | Inter-Quartile Range 0.0 to 1000.0 | mg | |
| Change From Baseline in CRD of Peanut Protein to Month 12 | Part A Viaskin Peanut 250 mcg | 540.0 | Inter-Quartile Range 0.0 to 2930.0 | mg | |
| Change From Baseline in CRD of Peanut Protein to Month 12 | Part A Viaskin Peanut 100 mcg | 1250.0 | Inter-Quartile Range 2.5 to 3000.0 | mg | |
| Change From Baseline in CRD of Peanut Protein to Month 12 | Part A Placebo | 1000.0 | Inter-Quartile Range 300.0 to 2560.0 | mg | |
| ED of Peanut Protein at Month 12 Using ANCOVA Model | Part B Viaskin Peanut 250 mcg | 659.36 | 95% Confidence Interval 553.84 to 784.99 | mg | |
| ED of Peanut Protein at Month 12 Using ANCOVA Model | Part B Placebo | 223.12 | 95% Confidence Interval 173.40 to 287.09 | mg | |
| ED of Peanut Protein at Month 12 Using ANCOVA Model | Part A Viaskin Peanut 250 mcg | 526.31 | 95% Confidence Interval 151.15 to 1832.58 | mg | |
| ED of Peanut Protein at Month 12 Using ANCOVA Model | Part A Viaskin Peanut 100 mcg | 730.38 | 95% Confidence Interval 254.17 to 2098.83 | mg | |
| ED of Peanut Protein at Month 12 Using ANCOVA Model | Part A Placebo | 760.60 | 95% Confidence Interval 325.34 to 1778.17 | mg |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03211247/results